BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23851115)

  • 1. Design, synthesis and biological evaluation of new aryl thiosemicarbazone as antichagasic candidates.
    Blau L; Menegon RF; Trossini GH; Molino JV; Vital DG; Cicarelli RM; Passerini GD; Bosquesi PL; Chin CM
    Eur J Med Chem; 2013 Sep; 67():142-51. PubMed ID: 23851115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain.
    Espíndola JW; Cardoso MV; Filho GB; Oliveira E Silva DA; Moreira DR; Bastos TM; Simone CA; Soares MB; Villela FS; Ferreira RS; Castro MC; Pereira VR; Murta SM; Sales Junior PA; Romanha AJ; Leite AC
    Eur J Med Chem; 2015 Aug; 101():818-35. PubMed ID: 26231082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
    Magalhaes Moreira DR; de Oliveira AD; Teixeira de Moraes Gomes PA; de Simone CA; Villela FS; Ferreira RS; da Silva AC; dos Santos TA; Brelaz de Castro MC; Pereira VR; Leite AC
    Eur J Med Chem; 2014 Mar; 75():467-78. PubMed ID: 24561675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, docking, and in vitro activity of thiosemicarbazones, aminoacyl-thiosemicarbazides and acyl-thiazolidones against Trypanosoma cruzi.
    Leite AC; de Lima RS; Moreira DR; Cardoso MV; Gouveia de Brito AC; Farias Dos Santos LM; Hernandes MZ; Kiperstok AC; de Lima RS; Soares MB
    Bioorg Med Chem; 2006 Jun; 14(11):3749-57. PubMed ID: 16458521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of New Thiosemicarbazones and Semicarbazones Containing the 1,2,3-1H-triazole-isatin Scaffold: Trypanocidal, Cytotoxicity, Electrochemical Assays, and Molecular Docking.
    Silva BNM; Sales Junior PA; Romanha AJ; Murta SMF; Lima CHS; Albuquerque MG; D'Elia E; Rodrigues JGA; Ferreira VF; Silva FC; Pinto AC; Silva BV
    Med Chem; 2019; 15(3):240-256. PubMed ID: 30332972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.
    Greenbaum DC; Mackey Z; Hansell E; Doyle P; Gut J; Caffrey CR; Lehrman J; Rosenthal PJ; McKerrow JH; Chibale K
    J Med Chem; 2004 Jun; 47(12):3212-9. PubMed ID: 15163200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation.
    Cardoso MV; de Siqueira LR; da Silva EB; Costa LB; Hernandes MZ; Rabello MM; Ferreira RS; da Cruz LF; Moreira DR; Pereira VR; de Castro MC; Bernhardt PV; Leite AC
    Eur J Med Chem; 2014 Oct; 86():48-59. PubMed ID: 25147146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity and mechanism of action against the protozoan parasite Trypanosoma cruzi of 5-nitrofuryl containing thiosemicarbazones.
    Aguirre G; Boiani L; Cerecetto H; Fernández M; González M; Denicola A; Otero L; Gambino D; Rigol C; Olea-Azar C; Faundez M
    Bioorg Med Chem; 2004 Sep; 12(18):4885-93. PubMed ID: 15336268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-(phenylthio)ethylidene derivatives as anti-Trypanosoma cruzi compounds: Structural design, synthesis and antiparasitic activity.
    Cardoso MVO; Oliveira Filho GB; Siqueira LRP; Espíndola JWP; Silva EBD; Mendes APO; Pereira VRA; Castro MCAB; Ferreira RS; Villela FS; Costa FMRD; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2019 Oct; 180():191-203. PubMed ID: 31306906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold(III) complexes with ONS-Tridentate thiosemicarbazones: Toward selective trypanocidal drugs.
    Rettondin AR; Carneiro ZA; Gonçalves AC; Ferreira VF; Oliveira CG; Lima AN; Oliveira RJ; de Albuquerque S; Deflon VM; Maia PI
    Eur J Med Chem; 2016 Sep; 120():217-26. PubMed ID: 27191616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiosemicarbazone derivatives: Evaluation as cruzipain inhibitors and molecular modeling study of complexes with cruzain.
    Jasinski G; Salas-Sarduy E; Vega D; Fabian L; Martini MF; Moglioni AG
    Bioorg Med Chem; 2022 May; 61():116708. PubMed ID: 35334448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antiparasitic activity of new thiosemicarbazones in strains of Trypanosoma cruzi.
    Moreno-Rodríguez A; Salazar-Schettino PM; Bautista JL; Hernández-Luis F; Torrens H; Guevara-Gómez Y; Pina-Canseco S; Torres MB; Cabrera-Bravo M; Martinez CM; Pérez-Campos E
    Eur J Med Chem; 2014 Nov; 87():23-9. PubMed ID: 25238291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of thiosemicarbazones and semicarbazones as potential agents anti-Trypanosoma cruzi.
    Soares RO; Echevarria A; Bellieny MS; Pinho RT; de Leo RM; Seguins WS; Machado GM; Canto-Cavalheiro MM; Leon LL
    Exp Parasitol; 2011 Dec; 129(4):381-7. PubMed ID: 21939658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents.
    dos Santos Filho JM; Leite AC; de Oliveira BG; Moreira DR; Lima MS; Soares MB; Leite LF
    Bioorg Med Chem; 2009 Sep; 17(18):6682-91. PubMed ID: 19683450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From rational design to serendipity: Discovery of novel thiosemicarbazones as potent trypanocidal compounds.
    Braga SFP; Santos VC; Vieira RP; Silva EBD; Monti L; Krake SH; Martinez PDG; Dias LC; Caffrey CR; Siqueira-Neto JL; de Oliveira RB; Ferreira RS
    Eur J Med Chem; 2022 Dec; 244():114876. PubMed ID: 36343429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental and Computational Study of Aryl-thiosemicarbazones Inhibiting Cruzain Reveals Reversible Inhibition and a Stepwise Mechanism.
    Martins LC; de Oliveira RB; Lameira J; Ferreira RS
    J Chem Inf Model; 2023 Mar; 63(5):1506-1520. PubMed ID: 36802548
    [No Abstract]   [Full Text] [Related]  

  • 17. Organometallic Gold(III) Complex [Au(Hdamp)(L1
    Lopes CD; Possato B; Gaspari APS; Oliveira RJ; Abram U; Almeida JPA; Rocho FDR; Leitão A; Montanari CA; Maia PIS; da Silva JS; de Albuquerque S; Carneiro ZA
    ACS Infect Dis; 2019 Oct; 5(10):1698-1707. PubMed ID: 31419384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl thiosemicarbazones for the treatment of trypanosomatidic infections.
    Linciano P; Moraes CB; Alcantara LM; Franco CH; Pascoalino B; Freitas-Junior LH; Macedo S; Santarem N; Cordeiro-da-Silva A; Gul S; Witt G; Kuzikov M; Ellinger B; Ferrari S; Luciani R; Quotadamo A; Costantino L; Costi MP
    Eur J Med Chem; 2018 Feb; 146():423-434. PubMed ID: 29407968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cruzain inhibition by hydroxymethylnitrofurazone and nitrofurazone: investigation of a new target in Trypanosoma cruzi.
    Trossini GH; Malvezzi A; T-do Amaral A; Rangel-Yagui CO; Izidoro MA; Cezari MH; Juliano L; Chin CM; Menezes CM; Ferreira EI
    J Enzyme Inhib Med Chem; 2010 Feb; 25(1):62-7. PubMed ID: 20030510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo activity of certain thiosemicarbazones against Trypanosoma cruzi.
    Wilson HR; Revankar GR; Tolman RL
    J Med Chem; 1974 Jul; 17(7):760-1. PubMed ID: 4209583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.